Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

NCT05905068 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
Combination for Subgroup High LDL-c Patients With Other Comorbidities

Interventions

DRUG: RN0191 INJECTION

Sponsor

Ikaria Bioscience Pty Ltd